Attitudes and Experiential Factors Associated with Completion of mt-sDNA Test Kit for Colorectal Cancer Screening-Reference-Cited by-同舟云学术

Attitudes and Experiential Factors Associated with Completion of mt-sDNA Test Kit for Colorectal Cancer Screening

Published:2023-01 Issue: Volume:10 Page:
ISSN:2374-3735
Container-title:Journal of Patient Experience
language:en
Short-container-title:Journal of Patient Experience

Author:

Finney Rutten Lila J.¹,Zhu Xuan¹,Treiman Katherine²^ORCID,Madson Gabriel²,Southwell Brian²,Helmueller Leah³,Alam Shama³,Gates Carlye²^ORCID,Squiers Linda²

Affiliation:

1. Division of Epidemiology, Mayo Clinic, Rochester, MN, USA

2. RTI International, Research Triangle Park, NC, USA

3. Exact Sciences Corporation, Madison, WI, USA

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States. Despite the availability of multiple screening options, CRC screening is underutilized. We conducted a survey of patients (n = 2973) who were prescribed the multi-target stool DNA (mt-sDNA) screening test (commercialized as Cologuard® and manufactured by Exact Sciences Corporation) to understand attitudes and experiences that influence test completion and likelihood of future test completion. Using exploratory factor analyses, we developed three scales: Perceived Effectiveness, Perceived Ease of Use, and Perceived Comfort.

Funder

Exact Sciences Corporation

Publisher

SAGE Publications

Subject

Health Policy,Health (social science),Leadership and Management

Link

http://journals.sagepub.com/doi/pdf/10.1177/23743735231213765

Reference35 articles.

1. Annual report to the nation on the status of cancer, part 1: National cancer statistics

2. Cancer statistics, 2023

3. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

4. Screening for Colorectal Cancer